CD4+ T-cell immunity of SARS-CoV-2 patients determine pneumonia development
E. Naito, T. Uchida, S. Yamasaki, K. Hashimoto, Y. Miura, A. Shiono, T. Kawamura, A. Mouri, O. Yamaguchi, H. Imai, K. Kaira, M. Nemoto, K. Mitsutake, M. Nagata, H. Kagamu
This study identifies a specific CD4+ T-cell cluster associated with reduced pneumonia risk in SARS-CoV-2 patients, suggesting immune imbalance contributes to severe disease.
bioRxiv · May 31, 2023 · PreprintImmunology